Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

13.35

-0.59 (-4.23%)

At close: Jul 10, 2026, 4:00 PM EDT

13.50

+0.15 (1.12%)

After-hours: Jul 10, 2026, 7:57 PM EDT

Zevra Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	124.22	83.23	-105.51	-46.05	-26.77	-8.56
Depreciation & Amortization	2.77	4.05	6.39	1.01	0.94	0.26
Stock-Based Compensation	12.62	12.63	14.91	5.95	4.29	2.44
Other Adjustments	-72.74	-75	21.74	-0.33	3.22	16.66
Change in Receivables	-2.98	-11.98	6.87	-9.08	-6.77	1.05
Changes in Inventories	-1.29	-1.31	-8.87	0.21	0.15	-
Changes in Accounts Payable	-8.85	-15.59	-3.6	11.13	3.13	-1.11
Changes in Other Operating Activities	1.87	2.36	-1.59	3.63	3.09	-0.3
Operating Cash Flow	12.77	-1.6	-69.67	-33.54	-18.72	10.44
Capital Expenditures	-0.77	-0.84	-	-0.3	-0.09	-0.1
Sale of Property, Plant & Equipment	-	0.45	-	-	-	-
Proceeds from Sale of Intangible Assets	118.94	150	-	-	-	-
Purchases of Investments	-360.92	-309.99	-41.16	-45.81	-23.86	-15.42
Proceeds from Sale of Investments	254.47	178.5	25	59.12	1.33	-
Payments for Business Acquisitions	-	-	-	-30.4	-14.09	-
Other Investing Activities	-	-	-6	-	-	-
Investing Cash Flow	87.2	18.13	-22.16	-17.39	-36.72	-15.52
Long-Term Debt Issued	-	-	58.99	42.43	12.8	-
Long-Term Debt Repaid	-60.09	-	-42.7	-17.53	-	-37.92
Net Long-Term Debt Issued (Repaid)	-60.09	-	16.29	24.9	12.8	-37.92
Issuance of Common Stock	2.36	12.44	67.26	6.32	0.32	158.24
Repurchase of Common Stock	-	-	-	-3.45	-4.72	-2.81
Net Common Stock Issued (Repurchased)	2.36	12.44	67.26	2.88	-4.4	155.43
Other Financing Activities	-2.64	-0.37	-1.44	0.69	-0.05	-4.39
Financing Cash Flow	-42.35	12.06	82.11	28.46	8.35	113.11
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.63	0.03	0.45	0.04	0.2	-
Net Cash Flow	58.26	28.62	-9.26	-22.42	-46.88	108.02
Free Cash Flow	12	-2.43	-69.67	-33.83	-18.81	10.34
FCF Margin	9.81%	-2.29%	-295.04%	-123.20%	-179.86%	36.08%
Free Cash Flow Per Share	0.21	-0.04	-1.51	-0.95	-0.55	0.35
Levered Free Cash Flow	7.81	71.91	-96.89	-5.48	-21.53	-102.07
Unlevered Free Cash Flow	-1.62	-76.76	-79.84	-33.93	-36.08	6.45

SEC Filings: 10-K · 10-Q